Parietaria pollen allergy immunotherapy (Laboratorios LETI)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameParietaria pollen allergy immunotherapy (Laboratorios LETI)
Drug Alias NameDepigoid Parietaria judaica
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Leti Sl
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLaboratorios Leti Sl
Active IndicationsN/A
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A